From: "Barrett, Paul S"

From: "Barrett, Paul S" To: Jeffrey Epstein <jeevacation@gmail.com> CC: "Giuffrida, David J" Subject: RE: To Do Date: Tue, 13 Mar 2012 14:35:09 +0000 Jeffrey I think we should buy another 1MM of this RBS bond. I think this has some decent upside potential. Paul Paul Barrett, CFA Managing Director Global Investment Opportunities Group JPMorgan Private Bank 320 Park Avenue, 14th Floor, New York, NY 10022 NMLS ID# 853441 From: Jeffrey Epstein [mailto:jeevacation@gmail.com] Sent: Monday, March 12, 2012 12:30 PM To: Barrett, Paul S Subject: Re: To Do ok On Mon, Mar 12, 2012 at 11:11 AM, Barrett, Paul S < Jeffrey RBS just issued a new bond wrote: RBS 13.125%2022 in AUD. I think we should buy $2MM of this and hedge it back into USD. The yield in AUD is 12.57%. Hedge cost is around 4% so we are looking at 8.57% yield in USD. Let me know Paul Paul Barrett, CFA Managing Director Global Investment Opportunities Group JPMorgan Private Bank 320 Park Avenue, 14th Floor, New York, NY 10022 EFTA00930930 NMLS ID# 853441 This email is confidential and subject to important disclaimers and conditions including on offers for the purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal privilege, and legal entity disclaimers, available at The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to jeevacation@gmail.com, and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved This email is confidential and subject to important disclaimers and conditions including on offers for the purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal privilege, and legal entity disclaimers, available at EFTA00930931